GLP-1S 20MG is a synthetic analogue of glucagon-like peptide-1 (GLP-1) developed exclusively for laboratory and scientific research. It is studied for its involvement in metabolic regulation, insulin signaling pathways, and cardiovascular-related mechanisms. Its enhanced stability and close structural similarity to endogenous GLP-1 allow for consistent performance in controlled experimental models.

This compound is intended solely for research use and is not approved for human use, treatment, or diagnostic applications.